S, W., B, V., S, R., J, A., R, B., S, B., . . . O, M. (2023). Single-agent gemcitabine in patients with advanced, pre-treated angiosarcoma: A multicenter, retrospective study. Cancer medicine, 12(3), 3160. https://doi.org/10.1002/cam4.5147
Chicago Style (17th ed.) CitationS, Watson, et al. "Single-agent Gemcitabine in Patients with Advanced, Pre-treated Angiosarcoma: A Multicenter, Retrospective Study." Cancer Medicine 12, no. 3 (2023): 3160. https://doi.org/10.1002/cam4.5147.
MLA (9th ed.) CitationS, Watson, et al. "Single-agent Gemcitabine in Patients with Advanced, Pre-treated Angiosarcoma: A Multicenter, Retrospective Study." Cancer Medicine, vol. 12, no. 3, 2023, p. 3160, https://doi.org/10.1002/cam4.5147.
Warning: These citations may not always be 100% accurate.